Macrophage Heterogeneity and Its Impact on Myocardial Ischemia-Reperfusion Injury: An Integrative Review

References

• Algoet M, Janssens S, Himmelreich U, et al. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med. 2022;33:357–366. doi:10.1016/j.tcm.2022.02.005
   PubMed Web of Science ®Google Scholar
• Heusch G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol. 2020;17(12):773–789. doi:10.1038/s41569-020-0403-y
   PubMed Web of Science ®Google Scholar
• Davidson SM, Ferdinandy P, Andreadou I, et al. Multitarget strategies to reduce myocardial ischemia/reperfusion injury: JACC review topic of the week. J Am Coll Cardiol. 2019;73(1):89–99. doi:10.1016/j.jacc.2018.09.086
   PubMed Web of Science ®Google Scholar
• Shen Y, Liu X, Shi J, Wu X. Involvement of Nrf2 in myocardial ischemia and reperfusion injury. Int J Biol Macromol. 2019;125:496–502. doi:10.1016/j.ijbiomac.2018.11.190
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou H. Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia-reperfusion injury. Acta pharmaceutica Sinica B. 2020;10(10):1866–1879. doi:10.1016/j.apsb.2020.03.004
   PubMed Web of Science ®Google Scholar
• Heusch G. Myocardial ischemia: lack of coronary blood flow or myocardial oxygen supply/demand imbalance? Circ Res. 2016;119(2):194–196. doi:10.1161/CIRCRESAHA.116.308925
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264. doi:10.1016/j.jacc.2018.08.1038
   PubMed Web of Science ®Google Scholar
• Peet C, Ivetic A, Bromage DI, Shah AM. Cardiac monocytes and macrophages after myocardial infarction. Cardiovasc Res. 2020;116(6):1101–1112. doi:10.1093/cvr/cvz336
   PubMed Web of Science ®Google Scholar
• Crea F, Libby P. Acute coronary syndromes: the way forward from mechanisms to precision treatment. Circulation. 2017;136(12):1155–1166. doi:10.1161/CIRCULATIONAHA.117.029870
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. Pathophysiology of myocardial infarction. Compreh Physiol. 2015;5(4):1841–1875.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Investig. 2013;123(1):92–100. doi:10.1172/JCI62874
   PubMed Web of Science ®Google Scholar
• Timmers L, Pasterkamp G, de Hoog VC, Arslan F, Appelman Y, de Kleijn DP. The innate immune response in reperfused myocardium. Cardiovasc Res. 2012;94(2):276–283. doi:10.1093/cvr/cvs018
   PubMed Web of Science ®Google Scholar
• Geijtenbeek TB, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol. 2009;9(7):465–479. doi:10.1038/nri2569
   PubMed Web of Science ®Google Scholar
• Veltman D, Wu M, Pokreisz P, et al. Clec4e-receptor signaling in myocardial repair after ischemia-reperfusion injury. J Am Coll Cardiol Basic Trans Science. 2021;6(8):631–646. doi:10.1016/j.jacbts.2021.07.001
   Google Scholar
• Sánchez-Hernández CD, Torres-Alarcón LA, González-Cortés A, Peón AN. Ischemia/reperfusion injury: pathophysiology, current clinical management, and potential preventive approaches. Mediators Inflammation. 2020;2020:8405370. doi:10.1155/2020/8405370
   PubMed Web of Science ®Google Scholar
• Hahn JY, Song YB, Kim EK, et al. Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation. 2013;128(17):1889–1896. doi:10.1161/CIRCULATIONAHA.113.001690
   PubMed Web of Science ®Google Scholar
• Engstrøm T, Kelbæk H, Helqvist S, et al. Effect of ischemic postconditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: a randomized clinical trial. JAMA Cardiol. 2017;2(5):490–497. doi:10.1001/jamacardio.2017.0022
   PubMed Web of Science ®Google Scholar
• Cung TT, Morel O, Cayla G, et al. Cyclosporine before PCI in patients with acute myocardial infarction. N Engl J Med. 2015;373(11):1021–1031. doi:10.1056/NEJMoa1505489
   PubMed Web of Science ®Google Scholar
• Selker HP, Beshansky JR, Sheehan PR, et al. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA. 2012;307(18):1925–1933. doi:10.1001/jama.2012.426
   PubMed Web of Science ®Google Scholar
• Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496(7446):445–455. doi:10.1038/nature12034
   PubMed Web of Science ®Google Scholar
• Hulsmans M, Clauss S, Xiao L, et al. Macrophages facilitate electrical conduction in the heart. Cell. 2017;169(3):510–522.e520. doi:10.1016/j.cell.2017.03.050
   PubMed Web of Science ®Google Scholar
• Honold L, Nahrendorf M. Resident and monocyte-derived macrophages in cardiovascular disease. Circ Res. 2018;122(1):113–127. doi:10.1161/CIRCRESAHA.117.311071
   PubMed Web of Science ®Google Scholar
• Swirski FK, Nahrendorf M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat Rev Immunol. 2018;18(12):733–744. doi:10.1038/s41577-018-0065-8
   PubMed Web of Science ®Google Scholar
• Pinto AR, Paolicelli R, Salimova E, et al. An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLoS One. 2012;7(5):e36814. doi:10.1371/journal.pone.0036814
   PubMed Web of Science ®Google Scholar
• Epelman S, Lavine KJ, Beaudin AE, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity. 2014;40(1):91–104. doi:10.1016/j.immuni.2013.11.019
   PubMed Web of Science ®Google Scholar
• Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity. 2014;41(1):21–35. doi:10.1016/j.immuni.2014.06.013
   PubMed Web of Science ®Google Scholar
• Leid J, Carrelha J, Boukarabila H, Epelman S, Jacobsen SE, Lavine KJ. Primitive embryonic macrophages are required for coronary development and maturation. Circ Res. 2016;118(10):1498–1511. doi:10.1161/CIRCRESAHA.115.308270
   PubMed Web of Science ®Google Scholar
• Bajpai G, Schneider C, Wong N, et al. The human heart contains distinct macrophage subsets with divergent origins and functions. Nat Med. 2018;24(8):1234–1245. doi:10.1038/s41591-018-0059-x
   PubMed Web of Science ®Google Scholar
• Bajpai G, Bredemeyer A, Li W, et al. Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury. Circ Res. 2019;124(2):263–278. doi:10.1161/CIRCRESAHA.118.314028
   PubMed Web of Science ®Google Scholar
• Jian Y, Zhou X, Shan W, et al. Crosstalk between macrophages and cardiac cells after myocardial infarction. Cell Commun Signal. 2023;21(1):109. doi:10.1186/s12964-023-01105-4
   PubMed Web of Science ®Google Scholar
• Dutta P, Sager HB, Stengel KR, et al. Myocardial infarction activates CCR2(+) hematopoietic stem and progenitor cells. Cell Stem Cell. 2015;16(5):477–487. doi:10.1016/j.stem.2015.04.008
   PubMed Web of Science ®Google Scholar
• Frantz S, Nahrendorf M. Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res. 2014;102(2):240–248. doi:10.1093/cvr/cvu025
   PubMed Web of Science ®Google Scholar
• Epelman S, Liu PP, Mann DL. Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol. 2015;15(2):117–129. doi:10.1038/nri3800
   PubMed Web of Science ®Google Scholar
• Majmudar MD, Keliher EJ, Heidt T, et al. Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation. 2013;127(20):2038–2046. doi:10.1161/CIRCULATIONAHA.112.000116
   PubMed Web of Science ®Google Scholar
• Ma Y, Mouton AJ, Lindsey ML. Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction. Translat Res. 2018;191:15–28. doi:10.1016/j.trsl.2017.10.001
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. J Cardiovasc Pharmacol. 2014;63(3):185–195. doi:10.1097/FJC.0000000000000003
   PubMed Web of Science ®Google Scholar
• Jung K, Kim P, Leuschner F, et al. Endoscopic time-lapse imaging of immune cells in infarcted mouse hearts. Circ Res. 2013;112(6):891–899. doi:10.1161/CIRCRESAHA.111.300484
   PubMed Web of Science ®Google Scholar
• Kubota A, Frangogiannis NG. Macrophages in myocardial infarction. Am J Physiol Cell Physiol. 2022;323(4):C1304–c1324. doi:10.1152/ajpcell.00230.2022
   PubMed Web of Science ®Google Scholar
• Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119(1):91–112. doi:10.1161/CIRCRESAHA.116.303577
   PubMed Web of Science ®Google Scholar
• Pinto AR, Ilinykh A, Ivey MJ, et al. Revisiting cardiac cellular composition. Circ Res. 2016;118(3):400–409. doi:10.1161/CIRCRESAHA.115.307778
   PubMed Web of Science ®Google Scholar
• Wan E, Yeap XY, Dehn S, et al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res. 2013;113(8):1004–1012. doi:10.1161/CIRCRESAHA.113.301198
   PubMed Web of Science ®Google Scholar
• Jia D, Chen S, Bai P, et al. Cardiac resident macrophage-derived legumain improves cardiac repair by promoting clearance and degradation of apoptotic cardiomyocytes after myocardial infarction. Circulation. 2022;145(20):1542–1556. doi:10.1161/CIRCULATIONAHA.121.057549
   PubMed Web of Science ®Google Scholar
• Zagórska A, Través PG, Lew ED, Dransfield I, Lemke G. Diversification of TAM receptor tyrosine kinase function. Nat Immunol. 2014;15(10):920–928. doi:10.1038/ni.2986
   PubMed Web of Science ®Google Scholar
• Cai B, Thorp EB, Doran AC, et al. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J Clin Investig. 2017;127(2):564–568. doi:10.1172/JCI90520
   PubMed Web of Science ®Google Scholar
• Cai B, Thorp EB, Doran AC, et al. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proc Natl Acad Sci USA. 2016;113(23):6526–6531. doi:10.1073/pnas.1524292113
   PubMed Web of Science ®Google Scholar
• Zhang S, Yeap XY, DeBerge M, et al. Acute CD47 blockade during ischemic myocardial reperfusion enhances phagocytosis-associated cardiac repair. J Am Coll Cardiol Basic Trans Science. 2017;2(4):386–397. doi:10.1016/j.jacbts.2017.03.013
   Google Scholar
• Tang X, Liu Z, Li X, Wang J, Li L. Cannabinoid receptors in myocardial injury: a brother born to rival. Int J Mol Sci. 2021;22(13). doi:10.3390/ijms22136886
   Web of Science ®Google Scholar
• Defer N, Wan J, Souktani R, et al. The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy. FASEB J. 2009;23(7):2120–2130. doi:10.1096/fj.09-129478
   PubMed Web of Science ®Google Scholar
• van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol. 2010;7(1):30–37. doi:10.1038/nrcardio.2009.199
   PubMed Web of Science ®Google Scholar
• Weber KT, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol. 2013;10(1):15–26. doi:10.1038/nrcardio.2012.158
   PubMed Web of Science ®Google Scholar
• Kologrivova I, Shtatolkina M, Suslova T, Ryabov V. Cells of the Immune System in Cardiac Remodeling: main Players in Resolution of Inflammation and Repair After Myocardial Infarction. Front Immunol. 2021;12:664457. doi:10.3389/fimmu.2021.664457
   PubMed Web of Science ®Google Scholar
• Ferraro B, Leoni G, Hinkel R, et al. Pro-angiogenic macrophage phenotype to promote myocardial repair. J Am Coll Cardiol. 2019;73(23):2990–3002. doi:10.1016/j.jacc.2019.03.503
   PubMed Web of Science ®Google Scholar
• Kubota A, Suto A, Suzuki K, Kobayashi Y, Nakajima H. Matrix metalloproteinase-12 produced by Ly6C(low) macrophages prolongs the survival after myocardial infarction by preventing neutrophil influx. J Mol Cell Cardiol. 2019;131:41–52. doi:10.1016/j.yjmcc.2019.04.007
   PubMed Web of Science ®Google Scholar
• Ramos G, Hofmann U, Frantz S. Myocardial fibrosis seen through the lenses of T-cell biology. J Mol Cell Cardiol. 2016;92:41–45. doi:10.1016/j.yjmcc.2016.01.018
   PubMed Web of Science ®Google Scholar
• Toor IS, Rückerl D, Mair I, et al. Eosinophil deficiency promotes aberrant repair and adverse remodeling following acute myocardial infarction. J Am Coll Cardiol Basic Trans Science. 2020;5(7):665–681. doi:10.1016/j.jacbts.2020.05.005
   Google Scholar
• Xu JY, Xiong YY, Tang RJ, et al. Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction. Cardiovasc Res. 2022;118(9):2165–2178. doi:10.1093/cvr/cvab237
   PubMed Web of Science ®Google Scholar
• Leuschner F, Rauch PJ, Ueno T, et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med. 2012;209(1):123–137. doi:10.1084/jem.20111009
   PubMed Web of Science ®Google Scholar
• Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341–355. doi:10.1016/j.cell.2011.04.005
   PubMed Web of Science ®Google Scholar
• Patel B, Bansal SS, Ismahil MA, et al. CCR2(+) monocyte-derived infiltrating macrophages are required for adverse cardiac remodeling during pressure overload. J Am Coll Cardiol Basic Trans Science. 2018;3(2):230–244. doi:10.1016/j.jacbts.2017.12.006
   Google Scholar
• Yan X, Anzai A, Katsumata Y, et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. 2013;62:24–35. doi:10.1016/j.yjmcc.2013.04.023
   PubMed Web of Science ®Google Scholar
• Zhang F, Dang Y, Li Y, Hao Q, Li R, Qi X. Cardiac contractility modulation attenuate myocardial fibrosis by inhibiting TGF-β1/Smad3 signaling pathway in a rabbit model of chronic heart failure. Cell Physiol Biochem. 2016;39(1):294–302. doi:10.1159/000445624
   PubMedGoogle Scholar
• Ismail N, Wang Y, Dakhlallah D, et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood. 2013;121(6):984–995. doi:10.1182/blood-2011-08-374793
   PubMed Web of Science ®Google Scholar
• Ge X, Meng Q, Wei L, et al. Myocardial ischemia-reperfusion induced cardiac extracellular vesicles harbour proinflammatory features and aggravate heart injury. J Extracell Vesicles. 2021;10(4):e12072. doi:10.1002/jev2.12072
   PubMed Web of Science ®Google Scholar
• Chen H, Hou Y, Zhai Y, et al. Peli1 deletion in macrophages attenuates myocardial ischemia/reperfusion injury by suppressing M1 polarization. J Leukoc Bio. 2023;113(2):95–108. doi:10.1093/jleuko/qiac012
   PubMedGoogle Scholar
• DeBerge M, Glinton K, Subramanian M, et al. Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction. J Clin Investig. 2021;131(6). doi:10.1172/JCI139576
   PubMed Web of Science ®Google Scholar
• Fan Q, Tao R, Zhang H, et al. Dectin-1 contributes to myocardial ischemia/reperfusion injury by regulating macrophage polarization and neutrophil infiltration. Circulation. 2019;139(5):663–678. doi:10.1161/CIRCULATIONAHA.118.036044
   PubMed Web of Science ®Google Scholar
• Cadenas S, Aragonés J, Landázuri MO. Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease. Cardiovasc Res. 2010;88(2):219–228. doi:10.1093/cvr/cvq256
   PubMed Web of Science ®Google Scholar
• Wallert M, Ziegler M, Wang X, et al. α-Tocopherol preserves cardiac function by reducing oxidative stress and inflammation in ischemia/reperfusion injury. Redox Biol. 2019;26:101292. doi:10.1016/j.redox.2019.101292
   PubMed Web of Science ®Google Scholar
• Yao M, Lu Y, Shi L, et al. A ROS-responsive, self-immolative and self-reporting hydrogen sulfide donor with multiple biological activities for the treatment of myocardial infarction. Bioact Mater. 2022;9:168–182. doi:10.1016/j.bioactmat.2021.07.011
   PubMed Web of Science ®Google Scholar
• Fromen CA, Kelley WJ, Fish MB, et al. Neutrophil-particle interactions in blood circulation drive particle clearance and alter neutrophil responses in acute inflammation. ACS nano. 2017;11(11):10797–10807. doi:10.1021/acsnano.7b03190
   PubMed Web of Science ®Google Scholar
• Zhao T, Wu W, Sui L, et al. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioact Mater. 2022;7:47–72. doi:10.1016/j.bioactmat.2021.06.006
   PubMed Web of Science ®Google Scholar
• Wang Y, Li L, Zhao W, et al. Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity. acs nano. 2018;12(9):8943–8960. doi:10.1021/acsnano.8b02037
   PubMed Web of Science ®Google Scholar
• Kim SY, Jeong JM, Kim SJ, et al. Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex. Nat Commun. 2017;8(1):2247. doi:10.1038/s41467-017-02325-2
   PubMedGoogle Scholar
• Matsui Y, Takagi H, Qu X, et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res. 2007;100(6):914–922. doi:10.1161/01.RES.0000261924.76669.36
   PubMed Web of Science ®Google Scholar
• Yu L, Yang G, Zhang X, et al. Megakaryocytic leukemia 1 bridges epigenetic activation of NADPH oxidase in macrophages to cardiac ischemia-reperfusion injury. Circulation. 2018;138(24):2820–2836. doi:10.1161/CIRCULATIONAHA.118.035377
   PubMed Web of Science ®Google Scholar
• Li N, Guo X, Li R, Zhou J, Yu F, Yan X. p-Coumaric acid regulates macrophage polarization in myocardial ischemia/reperfusion by promoting the expression of indoleamine 2, 3-dioxygenase. Bioengineered. 2021;12(2):10971–10981. doi:10.1080/21655979.2021.2001924
   PubMed Web of Science ®Google Scholar
• Xu L, Zeng Z, Niu C, et al. Normothermic ex vivo heart perfusion with NLRP3 inflammasome inhibitor Mcc950 treatment improves cardiac function of circulatory death hearts after transplantation. Front Cardiovasc Med. 2023;10:1126391. doi:10.3389/fcvm.2023.1126391
   PubMed Web of Science ®Google Scholar
• Sun L, Lu WX, Li H, Feng DY, Nie JX. Total saponins of Aralia elata (Miq.) Seem. alleviate myocardial ischemia-reperfusion injury by promoting NLRP3-inflammasome inactivation via PI3K/Akt signaling. Kaohsiung J Med Sci. 2023;39(3):290–301. doi:10.1002/kjm2.12627
   PubMed Web of Science ®Google Scholar
• Cheng P, Yang G, Zhao X, et al. Precisely and efficiently enzyme response microspheres with immune removal escape loaded with MCC950 ameliorate cardiac dysfunction in acute myocardial infarction. J Biomed Nanotech. 2020;16(2):153–165. doi:10.1166/jbn.2020.2885
   PubMed Web of Science ®Google Scholar
• Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87(1):245–313. doi:10.1152/physrev.00044.2005
   PubMed Web of Science ®Google Scholar
• Tonelli C, Chio IIC, Tuveson DA. Transcriptional Regulation by Nrf2. Antioxid. Redox Signaling. 2018;29(17):1727–1745. doi:10.1089/ars.2017.7342
   PubMed Web of Science ®Google Scholar
• Rothzerg E, Ingley E, Mullin B, Xue W, Wood D, Xu J. The hippo in the room: targeting the hippo signalling pathway for osteosarcoma therapies. J Cell Physiol. 2021;236(3):1606–1615. doi:10.1002/jcp.29967
   PubMed Web of Science ®Google Scholar
• Xu B, Zhang J, Strom J, Lee S, Chen QM. Myocardial ischemic reperfusion induces de novo Nrf2 protein translation. BBA. 2014;1842(9):1638–1647. doi:10.1016/j.bbadis.2014.06.002
   PubMed Web of Science ®Google Scholar
• Fei Q, Liu J, Qiao L, et al. Mst1 attenuates myocardial ischemia/reperfusion injury following heterotopic heart transplantation in mice through regulating Keap1/Nrf2 axis. Biochem Biophys Res Commun. 2023;644:140–148. doi:10.1016/j.bbrc.2022.12.087
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang Z, Ruan J, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535(7610):153–158. doi:10.1038/nature18629
   PubMed Web of Science ®Google Scholar
• Shi J, Zhao Y, Wang Y, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514(7521):187–192.
   PubMed Web of Science ®Google Scholar
• Ding J, Wang K, Liu W, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535(7610):111–116. doi:10.1038/nature18590
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen Q, Jiao F, et al. Histone deacetylase 2 regulates ULK1 mediated pyroptosis during acute liver failure by the K68 acetylation site. Cell Death Dis. 2021;12(1):55. doi:10.1038/s41419-020-03317-9
   PubMed Web of Science ®Google Scholar
• Shi H, Gao Y, Dong Z, et al. GSDMD-mediated cardiomyocyte pyroptosis promotes myocardial I/R Injury. Circ Res. 2021;129(3):383–396. doi:10.1161/CIRCRESAHA.120.318629
   PubMed Web of Science ®Google Scholar
• Ye B, Chen X, Dai S, et al. Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes. Drug Des Devel Ther. 2019;13:975–990. doi:10.2147/DDDT.S195412
   PubMed Web of Science ®Google Scholar
• Fagerberg L, Hallström BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13(2):397–406. doi:10.1074/mcp.M113.035600
   PubMed Web of Science ®Google Scholar
• Rieckmann JC, Geiger R, Hornburg D, et al. Social network architecture of human immune cells unveiled by quantitative proteomics. Nat Immunol. 2017;18(5):583–593. doi:10.1038/ni.3693
   PubMed Web of Science ®Google Scholar
• Ye X, Zhang P, Zhang Y, et al. GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis. Front Immunol. 2022;13:893914. doi:10.3389/fimmu.2022.893914
   PubMed Web of Science ®Google Scholar
• Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and mitophagy in cardiovascular disease. Circ Res. 2017;120(11):1812–1824. doi:10.1161/CIRCRESAHA.117.311082
   PubMed Web of Science ®Google Scholar
• Sciarretta S, Maejima Y, Zablocki D, Sadoshima J. The role of autophagy in the heart. Annu Rev Physiol. 2018;80:1–26. doi:10.1146/annurev-physiol-021317-121427
   PubMed Web of Science ®Google Scholar
• Ma LL, Ma X, Kong FJ, et al. Mammalian target of rapamycin inhibition attenuates myocardial ischaemia-reperfusion injury in hypertrophic heart. J Cell & Mol Med. 2018;22(3):1708–1719. doi:10.1111/jcmm.13451
   PubMed Web of Science ®Google Scholar
• Li Y, Liang P, Jiang B, et al. CARD9 promotes autophagy in cardiomyocytes in myocardial ischemia/reperfusion injury via interacting with Rubicon directly. Bas Res Cardiol. 2020;115(3):29. doi:10.1007/s00395-020-0790-6
   PubMed Web of Science ®Google Scholar
• Zhang J, Hu S, Gao Y, et al. Galangin alleviated myocardial ischemia-reperfusion injury by enhancing autophagic flux and inhibiting inflammation. Eur J Pharmacol. 2023;945:175621. doi:10.1016/j.ejphar.2023.175621
   PubMed Web of Science ®Google Scholar
• Gombozhapova A, Rogovskaya Y, Shurupov V, et al. Macrophage activation and polarization in post-infarction cardiac remodeling. J Biom Sci. 2017;24(1):13. doi:10.1186/s12929-017-0322-3
   PubMedGoogle Scholar
• Rendra E, Riabov V, Mossel DM, Sevastyanova T, Harmsen MC, Kzhyshkowska J. Reactive oxygen species (ROS) in macrophage activation and function in diabetes. Immunobiology. 2019;224(2):242–253. doi:10.1016/j.imbio.2018.11.010
   PubMed Web of Science ®Google Scholar
• Lu Y, Li C, Chen Q, et al. Microthrombus-targeting micelles for neurovascular remodeling and enhanced microcirculatory perfusion in acute ischemic stroke. Advan Mater. 2019;31(21):e1808361. doi:10.1002/adma.201808361
   PubMed Web of Science ®Google Scholar
• Abbate A, Salloum FN, Vecile E, et al. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation. 2008;117(20):2670–2683. doi:10.1161/CIRCULATIONAHA.107.740233
   PubMed Web of Science ®Google Scholar
• Woldbaek PR, Tønnessen T, Henriksen UL, et al. Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. Cardiovasc Res. 2003;59(1):122–131. doi:10.1016/S0008-6363(03)00339-0
   PubMed Web of Science ®Google Scholar
• Kim SJ, Chang HJ, Volin MV, et al. Macrophages are the primary effector cells in IL-7-induced arthritis. Cell Mol Immunol. 2020;17(7):728–740. doi:10.1038/s41423-019-0235-z
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhang W, Zhang L, et al. IL-7 suppresses macrophage autophagy and promotes liver pathology in Schistosoma japonicum-infected mice. J Cell & Mol Med. 2018;22(7):3353–3363. doi:10.1111/jcmm.13610
   PubMed Web of Science ®Google Scholar
• Bao C, Wang B, Yang F, Chen L. Blockade of interleukin-7 receptor shapes macrophage alternative activation and promotes functional recovery after spinal cord injury. Neuroscience. 2018;371:518–527. doi:10.1016/j.neuroscience.2017.10.022
   PubMed Web of Science ®Google Scholar
• Shive CL, Clagett B, McCausland MR, et al. Inflammation perturbs the IL-7 axis, promoting senescence and exhaustion that broadly characterize immune failure in treated HIV infection. J Acquir Immune Defic Syndr. 2016;71(5):483–492. doi:10.1097/QAI.0000000000000913
   PubMed Web of Science ®Google Scholar
• Kerdiles YM, Beisner DR, Tinoco R, et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol. 2009;10(2):176–184. doi:10.1038/ni.1689
   PubMed Web of Science ®Google Scholar
• Wei Y, Xing J, Su X, et al. IL-38 attenuates myocardial ischemia-reperfusion injury by inhibiting macrophage inflammation. Immun Inflamm Dis. 2023;11(6):e898. doi:10.1002/iid3.898
   PubMed Web of Science ®Google Scholar
• Li Z, Ding Y, Peng Y, et al. Effects of IL-38 on macrophages and myocardial ischemic injury. Front Immunol. 2022;13:894002. doi:10.3389/fimmu.2022.894002
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao XM, Fang L, et al. Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction. Arterioscler Thromb Vasc Biol. 2011;31(4):834–841. doi:10.1161/ATVBAHA.110.220467
   PubMed Web of Science ®Google Scholar
• Ziegler M, Wang X, Peter K. Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target. Cardiovasc Res. 2019;115(7):1178–1188. doi:10.1093/cvr/cvz070
   PubMed Web of Science ®Google Scholar
• An G, Wang H, Tang R, et al. P-selectin glycoprotein ligand-1 is highly expressed on Ly-6Chi monocytes and a major determinant for Ly-6Chi monocyte recruitment to sites of atherosclerosis in mice. Circulation. 2008;117(25):3227–3237. doi:10.1161/CIRCULATIONAHA.108.771048
   PubMed Web of Science ®Google Scholar
• Tan H, Song Y, Chen J, et al. Platelet-like fusogenic liposome-mediated targeting delivery of mir-21 improves myocardial remodeling by reprogramming macrophages post myocardial ischemia-reperfusion injury. Advan Sci. 2021;8:15.
   Web of Science ®Google Scholar
• Zhou Y, Liang Q, Wu X, et al. siRNA delivery against myocardial ischemia reperfusion injury mediated by reversibly camouflaged biomimetic nanocomplexes. Advan Mater. 2023;35(23):e2210691. doi:10.1002/adma.202210691
   PubMed Web of Science ®Google Scholar
• Weng X, Tan H, Huang Z, et al. Targeted delivery and ROS-responsive release of Resolvin D1 by platelet chimeric liposome ameliorates myocardial ischemia-reperfusion injury. J Nanobiotechnol. 2022;20(1):454. doi:10.1186/s12951-022-01652-x
   PubMed Web of Science ®Google Scholar
• Wang Y, Hou M, Duan S, et al. Macrophage-targeting gene silencing orchestrates myocardial microenvironment remodeling toward the anti-inflammatory treatment of ischemia-reperfusion (IR) injury. Bioact Mater. 2022;17:320–333. doi:10.1016/j.bioactmat.2022.01.026
   PubMed Web of Science ®Google Scholar
• Golpanian S, Wolf A, Hatzistergos KE, Hare JM. Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol Rev. 2016;96(3):1127–1168. doi:10.1152/physrev.00019.2015
   PubMed Web of Science ®Google Scholar
• Zhao J, Li X, Hu J, et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res. 2019;115(7):1205–1216. doi:10.1093/cvr/cvz040
   PubMed Web of Science ®Google Scholar
• Xian P, Hei Y, Wang R, et al. Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics. 2019;9(20):5956–5975. doi:10.7150/thno.33872
   PubMed Web of Science ®Google Scholar
• Ranganath SH, Levy O, Inamdar MS, Karp JM. Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012;10(3):244–258. doi:10.1016/j.stem.2012.02.005
   PubMed Web of Science ®Google Scholar
• Xiao C, Wang K, Xu Y, et al. Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b. Circ Res. 2018;123(5):564–578. doi:10.1161/CIRCRESAHA.118.312758
   PubMed Web of Science ®Google Scholar
• Xiao J, Pan Y, Li XH, et al. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death Dis. 2016;7(6):e2277. doi:10.1038/cddis.2016.181
   PubMed Web of Science ®Google Scholar
• Aliotta JM, Pereira M, Wen S, et al. Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice. Cardiovasc Res. 2016;110(3):319–330. doi:10.1093/cvr/cvw054
   PubMed Web of Science ®Google Scholar
• Song Y, Dou H, Li X, et al. Exosomal miR-146a contributes to the enhanced therapeutic efficacy of interleukin-1β-primed mesenchymal stem cells against sepsis. Stem Cells. 2017;35(5):1208–1221. doi:10.1002/stem.2564
   PubMed Web of Science ®Google Scholar
• Zhang L, Wei Q, Liu X, et al. Exosomal microRNA-98-5p from hypoxic bone marrow mesenchymal stem cells inhibits myocardial ischemia-reperfusion injury by reducing TLR4 and activating the PI3K/Akt signaling pathway. Int Immunopharmacol. 2021;101(Pt B):107592. doi:10.1016/j.intimp.2021.107592
   PubMedGoogle Scholar
• Gao L, Qiu F, Cao H, et al. Therapeutic delivery of microRNA-125a-5p oligonucleotides improves recovery from myocardial ischemia/reperfusion injury in mice and swine. Theranostics. 2023;13(2):685–703. doi:10.7150/thno.73568
   PubMed Web of Science ®Google Scholar
• Gallet R, Dawkins J, Valle J, et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J. 2017;38(3):201–211. doi:10.1093/eurheartj/ehw240
   PubMed Web of Science ®Google Scholar
• Liu B, Lee BW, Nakanishi K, et al. Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells. Nat Biomed Eng. 2018;2(5):293–303. doi:10.1038/s41551-018-0229-7
   PubMed Web of Science ®Google Scholar
• Wei Z, Chen Z, Zhao Y, et al. Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment. Biomaterials. 2021;275:121000. doi:10.1016/j.biomaterials.2021.121000
   PubMed Web of Science ®Google Scholar
• Li Q, Huang Z, Wang Q, et al. Targeted immunomodulation therapy for cardiac repair by platelet membrane engineering extracellular vesicles via hitching peripheral monocytes. Biomaterials. 2022;284:121529. doi:10.1016/j.biomaterials.2022.121529
   PubMed Web of Science ®Google Scholar
• van der Laan AM, Ter Horst EN, Delewi R, et al. Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J. 2014;35(6):376–385. doi:10.1093/eurheartj/eht331
   PubMed Web of Science ®Google Scholar